Megan E Piper
University of Wisconsin, Madison · University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health · UW-CTRI
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Megan E Piper as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:53 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06474299 · The Avenues Study: Dual Use CessationUniversity of Wisconsin, Madison · recruiting · Smoking Cessation, Electronic Cigarette Use · principal investigator
- Ph4NCT04188873 · Cessation Screening ProjectUniversity of Wisconsin, Madison · completed · Nicotine Dependence · study director
- Ph2NCT04084210 · Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette UseUniversity of Wisconsin, Madison · completed · Nicotine Dependence · principal investigator
- N/ANCT03978455 · A Pilot Study of the Learn, Connect, and Quit Mobile ApplicationUniversity of Wisconsin, Madison · completed · Smoking, Smoking Cessation · principal investigator
- N/ANCT02527980 · E-Cigarettes: Dynamic Patterns of Use and Health EffectsUniversity of Wisconsin, Madison · completed · Smoking, Nicotine Dependence · principal investigator
- Ph4NCT01116986 · Identifying Optimal Smoking Cessation Intervention Components (Cessation)University of Wisconsin, Madison · completed · Smoking, Smoking Cessation, Nicotine Dependence · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A randomized comparative effectiveness trial of nicotine pouches for cigarette substitution: A question of public healthR01CA291761 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2024 to 2026 · $752,489 awarded in 2026Same name and institution; not confirmed by an ID
- Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and VapeR01CA290895 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2024 to 2026 · $855,777 awarded in 2026Grant number is on one of their registry trials
- Project 1: Optimizing Smoking Cessation Treatment in Primary Care: A Factorial Screening Experiment (Cessation Screening)P01CA180945 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2014 to 2023 · $96,238 awarded in 2023Grant number is on one of their registry trials
- Tailoring Online Continence Promotion for WomenR01DK128349 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2023 · $311,000 awarded in 2023Same name and institution; not confirmed by an ID
- SRNT 2022 Annual MeetingR13FD007549 · FDA · SOCIETY FOR RESEARCH ON NICOTINE/TOBACCO · fiscal years 2022 · $50,000 awarded in 2022Same name and institution; not confirmed by an ID
- Understanding the real-world impact of the use of three alternate nicotine-delivery products on combustible cigarette useR01CA239309 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2019 to 2021 · $466,163 awarded in 2021Grant number is on one of their registry trials
- E-Cigarettes: Dynamic Patterns of Use and Health EffectsR01CA190025 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2015 to 2019 · $867,680 awarded in 2019Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer CareR35CA197573 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MICHAEL C FIORE · fiscal years 2015 to 2026Named on NCT03978455
- Identifying Optimal, Translatable Tobacco Cessation Interention ComponentsP50CA143188 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Timothy B Baker · fiscal years 2009 to 2013Named on NCT01116986
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:53 UTC. The ranking covers the 200 most relevant of 72 PubMed records, and a shared surname and initials can bring in a namesake. All 72 on PubMed
- A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.PLoS Genet · 2008216 citationsRCR 5.6
- Development of the Brief Wisconsin Inventory of Smoking Dependence Motives.Nicotine Tob Res · 2010190 citationsRCR 6.9
- A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.Arch Gen Psychiatry · 2009189 citationsRCR 6.3
- Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial.Am Heart J · 2011169 citationsRCR 5.3
- Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial.J Am Coll Cardiol · 2010165 citationsRCR 4.3
- 153 citationsRCR 7.8
- Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.Addiction · 2011146 citationsRCR 5.9
- Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation.J Consult Clin Psychol · 2010123 citationsRCR 4.9
- Tobacco withdrawal components and their relations with cessation success.Psychopharmacology (Berl) · 2011106 citationsRCR 4.0
- Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics.Arch Intern Med · 2009105 citationsRCR 3.4